PodParley PodParley
PodParley
Episode 177: steroids and CV risk, dementia guideline, fezolinetant for VMS, and osteoporosis screening episode artwork

EPISODE · Mar 26, 2025 · 31 MIN

Episode 177: steroids and CV risk, dementia guideline, fezolinetant for VMS, and osteoporosis screening

from Primary Care Update · host Mark Ebell

This week Gary, Mark, Kate and Henry discuss: adverse effects from inhaled steroids in asthma, Italian dementia guideline, fezolinetant for treatment of vasomotor symptoms, and updated USPSTF recommendations for osteoporosis screening.Show notes and links:Asthma and risk of CV events: https://pubmed.ncbi.nlm.nih.gov/39088770/ GINA 2024 guidelines: https://ginasthma.org/2024-report/ Italian dementia guidelines: https://www.ncbi.nlm.nih.gov/pubmed/39544104 with link to full report in Inglese: https://www.iss.it/documents/d/guest/the-full-guideline-english-version Fezolinetant for vasomotor symptoms: https://pubmed.ncbi.nlm.nih.gov/39557487/USPSTF osteoporosis screening guideline: https://pubmed.ncbi.nlm.nih.gov/39808425/ Dietary assessment tool: https://epi.grants.cancer.gov/asa24/ Article on interval for next BMD screening based on initial result: https://pubmed.ncbi.nlm.nih.gov/22256806/

What this episode covers

This week Gary, Mark, Kate and Henry discuss: adverse effects from inhaled steroids in asthma, Italian dementia guideline, fezolinetant for treatment of vasomotor symptoms, and updated USPSTF recommendations for osteoporosis screening.Show notes and links:Asthma and risk of CV events: https://pubmed.ncbi.nlm.nih.gov/39088770/ GINA 2024 guidelines: https://ginasthma.org/2024-report/ Italian dementia guidelines: https://www.ncbi.nlm.nih.gov/pubmed/39544104 with link to full report in Inglese: https://www.iss.it/documents/d/guest/the-full-guideline-english-version Fezolinetant for vasomotor symptoms: https://pubmed.ncbi.nlm.nih.gov/39557487/USPSTF osteoporosis screening guideline: https://pubmed.ncbi.nlm.nih.gov/39808425/ Dietary assessment tool: https://epi.grants.cancer.gov/asa24/ Article on interval for next BMD screening based on initial result: https://pubmed.ncbi.nlm.nih.gov/22256806/

NOW PLAYING

Episode 177: steroids and CV risk, dementia guideline, fezolinetant for VMS, and osteoporosis screening

0:00 31:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

gerald_russ_on_wm42

Jun 20, 2026 ·31m

gerald_roberts_is_live_with_tiffani_avatar

Jun 20, 2026 ·24m

gerald_roberts_is_live_with_steven_person

Jun 20, 2026 ·42m

gerald_roberts_is_live_with_shamir_dinero

Jun 20, 2026 ·26m

gerald_roberts_is_live_with_ruthie_jay

Jun 20, 2026 ·22m

gerald_roberts_is_live_with_pj_savage

Jun 20, 2026 ·37m

Similar Podcasts

Zero Așteptări Paul Puscas Podcastul nostru, este un refugiu de pace și introspecție în tumultul cotidian și în mijlocul așteptărilor adesea nerealiste ale societății. Ne-am dedicat acest spațiu digital pentru a oferi o platformă celor care doresc să exploreze diverse perspective și să participe la discuții deschise, autentice, fără prejudecăți sau anticipații predeterminate. Fiecare episod pe care îl lansăm este o invitație la reflecție și explorare personală, acoperind o gamă largă de subiecte, de la dezvoltare personală și spiritualitate, la cultură, artă și știință, prezentate întotdeauna într-o manieră acc The Health Odyssey: Navigating Tomorrow's Medicine Podcast Welcome to 'The Health Odyssey: Navigating Tomorrow's Medicine,' where we embark on an adventurous journey through the ever-evolving world of healthcare. Each episode is like a treasure map, guiding you through the rich tapestry of ancient healing arts mixed with futuristic tech wizardry. We’ll chat about the wild west of health data privacy, the corporate giants reshaping our care, and the mind-bending potential of psychedelics for mental wellness. Think of us as your trusty sidekicks, unraveling the mysteries of modern medicine while keeping it real and relatable. Let’s dive into the stories, the science, and the soul of healthcare, paving the way for a healthier tomorrow. Chosn Conversations: Beyond the Journal Chosn AI Journal Welcome to Chosn Conversations: Beyond the Journal, where your AI hosts explore the transformative power of conversational journaling and emotional intelligence. Each episode takes you beyond traditional journaling methods, diving deep into voice journaling techniques, mental wellness strategies, and the science behind AI-supported emotional health. We share inspiring user stories, analyze the latest research in digital mental wellness, and provide practical guidance for incorporating journaling into your self-care routine. Whether you're curious about AI therapy alternatives, looking for mental health support tools, or wanting to optimize your journaling practice, our conversations extend beyond the written page into meaningful audio experiences that offer evidence-based insights in an accessible, compassionate format. Join us as we navigate the intersection of technology and mental well-being, helping you track your emotional journey and build lasting resilience through the power of HealthCare Focus Corina Paraschiv We follow Health Care news and industry research so you don’t have to.

Frequently Asked Questions

How long is this episode of Primary Care Update?

This episode is 31 minutes long.

When was this Primary Care Update episode published?

This episode was published on March 26, 2025.

What is this episode about?

This week Gary, Mark, Kate and Henry discuss: adverse effects from inhaled steroids in asthma, Italian dementia guideline, fezolinetant for treatment of vasomotor symptoms, and updated USPSTF recommendations for osteoporosis screening.Show notes and...

Can I download this Primary Care Update episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!